Morpheus Ventures β 2023 Investments
5 investments dated 2023 Β· listed companies and verified rows first Β· show all
albo is a Mexican digital financial institution (IFPE, authorized by the CNBV) offering 100% digital personal accounts with a Mastercard-backed card for payments, transfers, spending management, and access to credit and crypto through commercial partners.
FintechSaaS
Co-investorsVentureSouqValar Ventures Llc
albo is a Mexican digital financial institution (IFPE authorized by the CNBV) offering a fully digital personal account with a Mastercard debit card, transfers, bill payments, and access to credit and crypto through commercial partners.
ConsumerEnterprise SoftwareFintech
Angel Sahagun Fernandez(Founder)in
Co-investorsFlourish VenturesMagma PartnersNazcaSouth QuadValar Ventures Llc
INGENIOUS is a construction management software platform that unifies project financials, project management, construction administration, capital planning, and reporting into one connected system.
Construction TechPropTechSaaSDover, US
Nicholas Carter(Executive Officer, Director, Promoter)Mark Cantaluppi(Executive Officer)Michael Denker(Executive Officer)
BoardMichael Spies(Director)inHoward Ko(Director)Sandor Valner(Director)
Co-investorsAmerican Family VenturesJLL Spark Global VenturesNavitas CapitalJLL Spark
RIOS built AI and computer-vision robotics systems for industrial automation β including GPU-accelerated object detection, robotic grasping, PLC/robot integration, and edge deployment β deployed across e-commerce, manufacturing, food processing, and wood products.
Advanced ManufacturingAI & Machine LearningRoboticsToronto
Clinton Smith(Founder)Marco Polsinelli(Director)George Carras(Director)Antoni Wisniowski(Executive Officer)Dilprit Grewal(Director)Elgin Farewell(Director)
Co-investorsGrit VenturesYamaha Motor Ventures
Ten63 develops drug-discovery technology that combines generative chemistry with quantum-accurate molecular simulation, including BEYOND (a large quantum chemistry model) and Sentinel (a virtual CSO for target selection), to design therapeutics against previously undruggable targets.
AI & Machine LearningBiotechDeep TechDurham, US
Mark A. Hallen(Executive Officer, Director)Marcel Frenkel(Executive Officer, Director)Damien Petty(Director)Jia Wei Xu(Director)
Co-investorsCape Fear BioCapitalDFJ DragonFundDraper AssociatesDuke Capital PartnersAlexandriaHatteras+2 more
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.